These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 35743105)
21. Dystroglycan: a possible mediator for reducing congenital muscular dystrophy? Sciandra F; Gawlik KI; Brancaccio A; Durbeej M Trends Biotechnol; 2007 Jun; 25(6):262-8. PubMed ID: 17416431 [TBL] [Abstract][Full Text] [Related]
22. Tumor suppressor function of laminin-binding alpha-dystroglycan requires a distinct beta3-N-acetylglucosaminyltransferase. Bao X; Kobayashi M; Hatakeyama S; Angata K; Gullberg D; Nakayama J; Fukuda MN; Fukuda M Proc Natl Acad Sci U S A; 2009 Jul; 106(29):12109-14. PubMed ID: 19587235 [TBL] [Abstract][Full Text] [Related]
23. AGO61-dependent GlcNAc modification primes the formation of functional glycans on α-dystroglycan. Yagi H; Nakagawa N; Saito T; Kiyonari H; Abe T; Toda T; Wu SW; Khoo KH; Oka S; Kato K Sci Rep; 2013 Nov; 3():3288. PubMed ID: 24256719 [TBL] [Abstract][Full Text] [Related]
24. A tumor suppressor function of laminin-binding alpha-dystroglycan. Bao X; Fukuda M Methods Enzymol; 2010; 479():387-96. PubMed ID: 20816178 [TBL] [Abstract][Full Text] [Related]
25. A conditional-lethal mutant of bacillus subtilis 168 with a thermosensitive glycerol-3-phosphate cytidylyltransferase, an enzyme specific for the synthesis of the major wall teichoic acid. Pooley HM; Abellan FX; Karamata D J Gen Microbiol; 1991 Apr; 137(4):921-8. PubMed ID: 1649892 [TBL] [Abstract][Full Text] [Related]
26. High throughput screening for compounds that alter muscle cell glycosylation identifies new role for N-glycans in regulating sarcolemmal protein abundance and laminin binding. Cabrera PV; Pang M; Marshall JL; Kung R; Nelson SF; Stalnaker SH; Wells L; Crosbie-Watson RH; Baum LG J Biol Chem; 2012 Jun; 287(27):22759-70. PubMed ID: 22570487 [TBL] [Abstract][Full Text] [Related]
27. The inside and out of dystroglycan post-translational modification. Moore CJ; Winder SJ Neuromuscul Disord; 2012 Nov; 22(11):959-65. PubMed ID: 22770978 [TBL] [Abstract][Full Text] [Related]
28. Large induces functional glycans in an O-mannosylation dependent manner and targets GlcNAc terminals on alpha-dystroglycan. Hu Y; Li ZF; Wu X; Lu Q PLoS One; 2011 Feb; 6(2):e16866. PubMed ID: 21347376 [TBL] [Abstract][Full Text] [Related]
29. HNK-1 sulfotransferase modulates α-dystroglycan glycosylation by 3-O-sulfation of glucuronic acid on matriglycan. Sheikh MO; Venzke D; Anderson ME; Yoshida-Moriguchi T; Glushka JN; Nairn AV; Galizzi M; Moremen KW; Campbell KP; Wells L Glycobiology; 2020 Sep; 30(10):817-829. PubMed ID: 32149355 [TBL] [Abstract][Full Text] [Related]
30. Breast cancer cells adapt to metabolic stress by increasing ethanolamine phospholipid synthesis and CTP:ethanolaminephosphate cytidylyltransferase-Pcyt2 activity. Zhu L; Bakovic M Biochem Cell Biol; 2012 Apr; 90(2):188-99. PubMed ID: 22339418 [TBL] [Abstract][Full Text] [Related]
31. Endogenous glucuronyltransferase activity of LARGE or LARGE2 required for functional modification of α-dystroglycan in cells and tissues. Inamori K; Willer T; Hara Y; Venzke D; Anderson ME; Clarke NF; Guicheney P; Bönnemann CG; Moore SA; Campbell KP J Biol Chem; 2014 Oct; 289(41):28138-48. PubMed ID: 25138275 [TBL] [Abstract][Full Text] [Related]
32. α-Dystroglycan hypoglycosylation affects cell migration by influencing β-dystroglycan membrane clustering and filopodia length: A multiscale confocal microscopy analysis. Palmieri V; Bozzi M; Signorino G; Papi M; De Spirito M; Brancaccio A; Maulucci G; Sciandra F Biochim Biophys Acta Mol Basis Dis; 2017 Sep; 1863(9):2182-2191. PubMed ID: 28572004 [TBL] [Abstract][Full Text] [Related]
33. Human natural killer-1 sulfotransferase (HNK-1ST)-induced sulfate transfer regulates laminin-binding glycans on α-dystroglycan. Nakagawa N; Manya H; Toda T; Endo T; Oka S J Biol Chem; 2012 Aug; 287(36):30823-32. PubMed ID: 22801424 [TBL] [Abstract][Full Text] [Related]
34. Hypoglycosylation of dystroglycan due to T192M mutation: a molecular insight behind the fact. Bhattacharya S; Das A; Ghosh S; Dasgupta R; Bagchi A Gene; 2014 Mar; 537(1):108-14. PubMed ID: 24361964 [TBL] [Abstract][Full Text] [Related]
35. Dystroglycan glycosylation and its role in matrix binding in skeletal muscle. Martin PT Glycobiology; 2003 Aug; 13(8):55R-66R. PubMed ID: 12736199 [TBL] [Abstract][Full Text] [Related]
37. biAb Mediated Restoration of the Linkage between Dystroglycan and Laminin-211 as a Therapeutic Approach for α-Dystroglycanopathies. Gumlaw N; Sevigny LM; Zhao H; Luo Z; Bangari DS; Masterjohn E; Chen Y; McDonald B; Magnay M; Travaline T; Yoshida-Moriguchi T; Fan W; Reczek D; Stefano JE; Qiu H; Beil C; Lange C; Rao E; Lukason M; Barry E; Brondyk WH; Zhu Y; Cheng SH Mol Ther; 2020 Feb; 28(2):664-676. PubMed ID: 31843448 [TBL] [Abstract][Full Text] [Related]
38. LARGE glycans on dystroglycan function as a tunable matrix scaffold to prevent dystrophy. Goddeeris MM; Wu B; Venzke D; Yoshida-Moriguchi T; Saito F; Matsumura K; Moore SA; Campbell KP Nature; 2013 Nov; 503(7474):136-40. PubMed ID: 24132234 [TBL] [Abstract][Full Text] [Related]
39. Chemical and Chemo-Enzymatic Syntheses of Glycans Containing Ribitol Phosphate Scaffolding of Matriglycan. Tamura JI; Tamura T; Hoshino S; Imae R; Kato R; Yokono M; Nagase M; Ohno S; Manabe N; Yamaguchi Y; Manya H; Endo T ACS Chem Biol; 2022 Jun; 17(6):1513-1523. PubMed ID: 35670527 [TBL] [Abstract][Full Text] [Related]
40. Dystroglycan and muscular dystrophies related to the dystrophin-glycoprotein complex. Sciandra F; Bozzi M; Bianchi M; Pavoni E; Giardina B; Brancaccio A Ann Ist Super Sanita; 2003; 39(2):173-81. PubMed ID: 14587215 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]